| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |